Purple Biotech Analyst Ratings
Purple Biotech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 910.1% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 08/31/2023 | 809.09% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 08/30/2023 | 809.09% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 07/21/2023 | 708.08% | JonesTrading | → $8 | Initiates Coverage On | → Buy |
| 05/17/2023 | 607.07% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/17/2023 | 1011.11% | Chardan Capital | → $11 | Reiterates | Buy → Buy |
| 02/09/2023 | 607.07% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/09/2023 | 1011.11% | Chardan Capital | → $11 | Reiterates | → Buy |
| 10/17/2022 | 607.07% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 09/08/2022 | 1011.11% | Chardan Capital | → $11 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/21/2023 | 910.1% | HC Wainwright & Co. | 9 美元 → 10 美元 | 維護 | 買 |
| 08/31/2023 | 809.09% | HC Wainwright & Co. | 7 美元 → 9 美元 | 維護 | 買 |
| 08/30/2023 | 809.09% | HC Wainwright & Co. | 7 美元 → 9 美元 | 維護 | 買 |
| 07/21/2023 | 708.08% | JonesTrading | → 8 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 05/17/2023 | 607.07% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 05/17/2023 | 1011.11% | 查丹資本 | → 11 美元 | 重申 | 購買 → 購買 |
| 02/09/2023 | 607.07% | HC Wainwright & Co. | → 7 美元 | 重申 | → 購買 |
| 02/09/2023 | 1011.11% | 查丹資本 | → 11 美元 | 重申 | → 購買 |
| 2022 年 10 月 17 日 | 607.07% | HC Wainwright & Co. | → 7 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 09/08/2022 | 1011.11% | 查丹資本 | → 11 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Purple Biotech (PPBT)?
紫光生物科技（PPBT）的目標價格是多少？
The latest price target for Purple Biotech (NASDAQ: PPBT) was reported by HC Wainwright & Co. on November 21, 2023. The analyst firm set a price target for $10.00 expecting PPBT to rise to within 12 months (a possible 910.10% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月21日公佈了紫色生物科技（納斯達克股票代碼：PPBT）的最新目標股價。該分析公司將目標股價定爲10.00美元，預計PPBT將在12個月內升至12個月內（可能上漲910.10％）。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Purple Biotech (PPBT)?
紫色生物科技（PPBT）的最新分析師評級是多少？
The latest analyst rating for Purple Biotech (NASDAQ: PPBT) was provided by HC Wainwright & Co., and Purple Biotech maintained their buy rating.
HC Wainwright & Co. 對紫色生物科技（納斯達克股票代碼：PPBT）的最新分析師評級由HC Wainwright & Co. 提供，紫色生物科技維持買入評級。
When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?
Purple Biotech（PPBT）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Purple Biotech的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Purple Biotech的最新評級是在2023年11月21日公佈的，因此您應該預計下一個評級將在2024年11月21日左右公佈。
Is the Analyst Rating Purple Biotech (PPBT) correct?
分析師評級紫色生物科技（PPBT）是否正確？
While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a maintained with a price target of $9.00 to $10.00. The current price Purple Biotech (PPBT) is trading at is $0.99, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的紫色生物科技（PPBT）評級維持不變，目標股價爲9.00美元至10.00美元。紫色生物科技（PPBT）目前的交易價格爲0.99美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。